Data / Research funding / Prescription Drug Abuse
Prescription Drug Abuse: 60 NIH awards ($27.7M) to 49 organizations
60 NIH awards ($27.7M) in the NIH spending category Prescription Drug Abuse, to 49 organizations, read 2026-11-03. NIH fiscal years 2021 to 2025.
SpecStream is the live web data engine for teams and agents. It reads the NIH and NSF award files each time the agencies update them, and this page is that reading, joined to the open federal funding opportunities on Grants.gov. Ask for the awards you track by topic, organization or state and new awards arrive in your sheet, CRM, Slack or agent as the agencies publish them.
- Topic
- NIH spending category
Awards
60 awards in the window.
| Award | Agency | Institute or division | Fiscal year | Amount in window | Start | End | Principal investigator | Source |
|---|---|---|---|---|---|---|---|---|
| Opiod Analgesic Reduction Study (OARS): Managing Acute Post-Operative Surgical Pain | NIH | National Institute of Dental & Craniofacial Research | 2021 | $3,127,499 | August 1, 2020 | July 31, 2024 | FELDMAN, CECILE | reporter.nih.gov |
| Development of an intranasal, long duration opioid antagonist to treat opioid overdose | NIH | National Institute on Drug Abuse | 2021 | $1,800,581 | May 1, 2018 | March 31, 2022 | CRYSTAL, ROGER | reporter.nih.gov |
| Development of a novel analgesic for mixed inflammatory and neuropathic pain states | NIH | National Institute of Neurological Disorders and Stroke | 2021 | $1,734,409 | September 15, 2021 | August 31, 2023 | GHETTI, ANDREA | reporter.nih.gov |
| Non-Opioid Post-Operative Pain Management Using Bupivacaine-loaded Poly(ester urea) Mesh | NIH | National Institute of General Medical Sciences | 2021 | $1,730,751 | September 13, 2021 | August 31, 2023 | YU, JIAYI | reporter.nih.gov |
| Application of Economics & Social psychology to improve Opioid Prescribing Safety (AESOPS) Trial | NIH | National Institute on Aging | 2021 | $1,225,740 | September 15, 2017 | August 31, 2023 | DOCTOR, JASON N. | reporter.nih.gov |
| BioMote for Opioid Use Disorder (OUD) Recovery | NIH | National Institute on Drug Abuse | 2021 | $1,193,511 | August 1, 2017 | May 31, 2023 | SCHMIDLE, PATRIK | reporter.nih.gov |
| Clinical and Genetic Study of Prescription Opioid Addiction | NIH | National Institute on Drug Abuse | 2021 | $737,349 | September 1, 2017 | May 31, 2024 | TROIANI, VANESSA | reporter.nih.gov |
| NON-DEPENDENT OPIOID MISUSERS AS GWAS CONTROLS | NIH | National Institute on Drug Abuse | 2021 | $648,323 | September 1, 2017 | May 31, 2023 | NELSON, ELLIOT C | reporter.nih.gov |
| Evaluation of Marijuana and Opioid Drug Interactions: Assessment of the Safety Profile, Abuse-Related Pharmacodynamic Effects and Models of Drug Intake | NIH | National Institute on Drug Abuse | 2021 | $609,253 | August 1, 2018 | May 31, 2025 | BABALONIS, SHANNA | reporter.nih.gov |
| Adapting the HOPE Online Support Intervention to Increase MAT Uptake Among OUD Patients | NIH | National Center for Complementary & Integrative Health | 2021 | $588,750 | September 28, 2019 | August 31, 2024 | YOUNG, SEAN | reporter.nih.gov |
| Intervention to Increase Naloxone Engagement and Distribution in Community Pharmacies: A Four-State Randomized Trial | NIH | National Institute on Drug Abuse | 2021 | $587,534 | May 1, 2020 | October 31, 2023 | GREEN, TRACI C | reporter.nih.gov |
| Reducing ethnic and language disparities in Spanish-speaking patients who receive opioids for postsurgical pain | NIH | National Institute on Drug Abuse | 2021 | $581,748 | September 30, 2020 | August 31, 2023 | URMAN, RICHARD D. | reporter.nih.gov |
| Bivalent Ligands as Chemical Probes to Study Opioid Abuse-enhanced HIV Infection | NIH | National Institute on Drug Abuse | 2021 | $567,877 | July 1, 2017 | May 31, 2023 | ZHANG, YAN | reporter.nih.gov |
| oPIOIDS: Prevention of Iatrogenic Opioid Dependence after Surgery | NIH | National Institute on Drug Abuse | 2021 | $561,528 | July 1, 2017 | April 30, 2023 | WALJEE, JENNIFER FILIP | reporter.nih.gov |
| Reducing Non-Medical Opioid Use: An automatically adaptive mHealth Intervention | NIH | National Institute on Drug Abuse | 2021 | $552,775 | May 1, 2016 | January 31, 2023 | BOHNERT, AMY S B | reporter.nih.gov |
| Probing mechanisms of amphetamine action at plasma membrane and vesicular transporters in vitro and in vivo | NIH | National Institute on Drug Abuse | 2021 | $539,654 | April 1, 2017 | January 31, 2023 | JAVITCH, JONATHAN A | reporter.nih.gov |
| Multi-organ-on-chip device for modeling opioid reinforcement and withdrawal, and the negative affective component of pain: a therapeutic screening tool. | NIH | National Center for Advancing Translational Sciences | 2021 | $531,057 | September 26, 2019 | July 31, 2022 | MAIDMENT, NIGEL T | reporter.nih.gov |
| Examining the Consequences of Reductions in Opioid Prescribing on Patients, Clinical Care, and Community Health | NIH | National Institute on Drug Abuse | 2021 | $514,868 | May 1, 2017 | February 29, 2024 | KNIGHT, KELLY RAY | reporter.nih.gov |
| OPTIMIZING OUTPATIENT ANESTHESIA: IMPROVING ANALGESIA AND REDUCING OPIOID MISADVENTURE | NIH | National Institute on Drug Abuse | 2021 | $505,171 | July 1, 2018 | December 31, 2023 | KHARASCH, EVAN D. | reporter.nih.gov |
| EpiCenter ? EPIdemiology of opioid prescribing in community health CENTERs | NIH | National Institute on Drug Abuse | 2021 | $490,523 | August 1, 2018 | April 30, 2022 | MUENCH, JOHN | reporter.nih.gov |
| Pharmacological and behavioral effects of MCAM: a long-acting, μ opioid receptor antagonist for treatment of opioid overdose and opioid abuse disorder | NIH | National Institute on Drug Abuse | 2021 | $461,788 | May 15, 2019 | January 31, 2023 | CLARKE, WILLIAM P | reporter.nih.gov |
| Novel opioids that protect against oral overdose and disrupt the progression to misuse, abuse, and addiction | NIH | National Institute on Drug Abuse | 2021 | $452,530 | June 15, 2018 | December 31, 2022 | JENKINS, THOMAS E | reporter.nih.gov |
| Neurobiological mechanisms of prescription opioid withdrawal | NIH | National Institute on Drug Abuse | 2021 | $447,386 | September 15, 2017 | December 31, 2022 | CHARTOFF, ELENA H | reporter.nih.gov |
| Real-time Predictors of Prescription Drug Misuse by College Students and Assessment of Misuse on Their Developmental Trajectories | NIH | National Institute on Drug Abuse | 2021 | $394,779 | May 16, 2021 | February 28, 2023 | PAPP, LAUREN M | reporter.nih.gov |
| Opioid Treatment and Recovery through a Safe Pain Management Program | NIH | National Institute on Drug Abuse | 2021 | $378,392 | September 30, 2018 | June 30, 2023 | PRICE-HAYWOOD, EBONI G | reporter.nih.gov |
| Role of SK2 channels in morphine dependence | NIH | National Institute on Drug Abuse | 2021 | $374,464 | May 1, 2017 | January 31, 2023 | MORON-CONCEPCION, JOSE A | reporter.nih.gov |
| A High School Program for Preventing Prescription Drug Abuse | NIH | National Institute on Drug Abuse | 2021 | $371,950 | May 1, 2017 | July 31, 2023 | WILLIAMS, CHRISTOPHER | reporter.nih.gov |
| The role of the VTA-lateral habenula circuit in opioid mediated behaviors | NIH | National Institute on Drug Abuse | 2021 | $356,625 | September 1, 2017 | June 30, 2023 | MARGOLIS, ELYSSA | reporter.nih.gov |
| Alternatives to prescription opioids: a precision medicine approach to harnessing endogenous opioids for pain relief and circumvention of prescription opioid abuse | NIH | National Institute on Drug Abuse | 2021 | $351,379 | August 1, 2017 | May 31, 2024 | STEWART, MARK G | reporter.nih.gov |
| Identification of cells and signaling mechanisms underlying opioid analgesia and side effects | NIH | National Institute on Drug Abuse | 2021 | $349,875 | June 1, 2020 | May 31, 2023 | SCHERRER, GREGORY | reporter.nih.gov |
| Mining Social Media Big Data for Toxicovigilance: Automating the Monitoring of Prescription Medication Abuse via Natural Language Processing and Machine Learning Methods | NIH | National Institute on Drug Abuse | 2021 | $332,121 | September 1, 2019 | May 31, 2023 | SARKER, ABEED H | reporter.nih.gov |
| The Microbiome in opioid use and abuse | NIH | National Institute on Drug Abuse | 2021 | $280,577 | June 1, 2020 | May 31, 2023 | WHISTLER, JENNIFER L | reporter.nih.gov |
| Targeting Leptin Pathway to Treat Opioid-Induced Respiratory Depression | NIH | National Institute on Drug Abuse | 2021 | $259,438 | November 15, 2020 | October 31, 2022 | POLOTSKY, VSEVOLOD Y | reporter.nih.gov |
| MyTPill: A Novel Strategy to Monitor Antiretroviral Adherence among HIV+ Prescription Opioid Users | NIH | National Institute on Drug Abuse | 2021 | $252,947 | June 1, 2019 | August 31, 2021 | BOYER, EDWARD W | reporter.nih.gov |
| Molecular basis for ligand and cell type specific regulation of opioid receptors | NIH | National Institute on Drug Abuse | 2021 | $249,000 | September 1, 2019 | August 31, 2023 | LOBINGIER, BRADEN | reporter.nih.gov |
| Characterization GPR83 and identification of small molecule ligands targeting this receptor for the treatment of substance use disorders. | NIH | National Institute on Drug Abuse | 2021 | $247,028 | December 1, 2020 | November 30, 2021 | DEVI, LAKSHMI A | reporter.nih.gov |
| Real Time Monitoring of Prescription Opioid and Cannabis Co-Use in Patients with Chronic Pain | NIH | National Institute on Drug Abuse | 2021 | $245,625 | March 15, 2020 | February 28, 2023 | THRUL, JOHANNES | reporter.nih.gov |
| In vivo characterization of opioid biased agonists | NIH | National Institute on Drug Abuse | 2021 | $245,568 | January 1, 2019 | November 30, 2022 | PARONIS, CAROL A | reporter.nih.gov |
| Connectomics of relapse to aggression seeking | NIH | National Institute on Drug Abuse | 2021 | $241,782 | August 1, 2019 | July 31, 2022 | GOLDEN, SAM | reporter.nih.gov |
| Opioid Support and Risk Reduction Online Platform | NIH | National Institute on Drug Abuse | 2021 | $238,994 | January 1, 2021 | December 31, 2022 | GARETT, RENEE | reporter.nih.gov |
| Impact of prenatal opioid exposure on long-range brain circuit connectivity and behavior | NIH | National Institute on Drug Abuse | 2021 | $231,250 | July 1, 2020 | April 1, 2022 | MILLER, COURTNEY A | reporter.nih.gov |
| Exploring steroid-based therapies to reduce opioid abuse | NIH | National Institute on Drug Abuse | 2021 | $190,625 | April 15, 2020 | March 31, 2023 | BORTOLATO, MARCO | reporter.nih.gov |
| iTransform: Wearable Biosensors to Detect the Evolution of Opioid Tolerance in Opioid Naïve Individuals | NIH | National Institute on Drug Abuse | 2021 | $188,616 | April 1, 2019 | March 31, 2023 | CARREIRO, STEPHANIE P | reporter.nih.gov |
| Pilot Implementation of Measurement-Based Care in Community Opioid Treatment Programs | NIH | National Institute on Drug Abuse | 2021 | $186,362 | April 1, 2021 | February 28, 2026 | SCOTT, KELLI | reporter.nih.gov |
| A Behavioral Intervention to Engage Emerging Adults in Addiction Treatment after a Non-fatal Opioid Overdose | NIH | National Institute on Drug Abuse | 2021 | $180,122 | July 15, 2017 | June 30, 2023 | BAGLEY, SARAH M | reporter.nih.gov |
| Understanding the Impact of Opioid Policies on the Opioid Epidemic Using Graphical Causal Models and Causal Discovery | NIH | National Institute on Drug Abuse | 2021 | $180,021 | June 15, 2020 | January 1, 2022 | JALAL, HAWRE | reporter.nih.gov |
| Adaptive Treatment Models for the Management of Drug Use Disorders | NIH | National Institute on Drug Abuse | 2021 | $177,902 | September 1, 2010 | April 30, 2024 | MCKAY, JAMES R. | reporter.nih.gov |
| Circuit-specific molecular mechanisms in fentanyl use and relapse | NIH | National Institute on Drug Abuse | 2021 | $175,792 | April 1, 2020 | September 30, 2021 | FOX, MEGAN ELIZABETH | reporter.nih.gov |
| Discovery of novel pharmacotherapeutic targets for opioid addiction | NIH | National Institute on Drug Abuse | 2021 | $171,504 | August 1, 2020 | November 30, 2021 | SMITH, ALEXANDER WANLESS | reporter.nih.gov |
| Developing a public health measure of built environment to assess risk of nonmedical opioid use and related mortality in urban and non-urban areas in New Jersey | NIH | National Institute on Drug Abuse | 2021 | $167,983 | April 15, 2020 | March 31, 2023 | TEMPALSKI, BARBARA | reporter.nih.gov |
| Nonmedical prescription drug misuse among US older adults: subtypes,motives, and diversion sources | NIH | National Institute on Drug Abuse | 2021 | $135,875 | August 15, 2017 | February 28, 2022 | SCHEPIS, TY STEPHEN | reporter.nih.gov |
| Metabotropic glutamate regulation of synaptic rewiring in opioid addiction | NIH | National Institute on Drug Abuse | 2021 | $77,142 | April 1, 2019 | March 31, 2022 | ZUCCA, STEFANO | reporter.nih.gov |
| Developing a Novel Mixed Opioid Agonist for the Treatment of OUD | NIH | National Institute on Drug Abuse | 2021 | $55,000 | May 24, 2021 | March 31, 2022 | VERSI, EBRAHIM | reporter.nih.gov |
| Development of the Strength Band Platform, a Technology Assisted Therapy Platform to Aid with Opioid Abuse Treatment. | NIH | National Institute on Drug Abuse | 2021 | $55,000 | September 15, 2020 | June 30, 2022 | REESER, DAVID | reporter.nih.gov |
| Pre-clinical assessments of dose-sparing and anti-addictive adjuvants to prevent the future abuse of opioid analgesics | NIH | National Institute on Drug Abuse | 2021 | $53,965 | September 30, 2020 | January 19, 2023 | WHITE, ALLISON | reporter.nih.gov |
| Opioid-induced changes to cannabinergic regulation of dopamine and motivation during protracted withdrawal | NIH | National Institute of Neurological Disorders and Stroke | 2021 | $31,156 | July 1, 2021 | June 30, 2022 | GOMEZ, DEVAN MARC | reporter.nih.gov |
| Identifying mechanisms and biomarkers predictive of individual variability in efficacy of vaccines against opioid use disorder | NIH | National Institute on Drug Abuse | 2021 | $26,961 | November 1, 2021 | August 19, 2022 | CROUSE, BETHANY K | reporter.nih.gov |
| Distress Tolerance and Benzodiazepine Discontinuation in Opioid Agonist Therapy | NIH | National Institute on Drug Abuse | 2021 | $15,459 | August 15, 2017 | September 11, 2021 | PARK, TAE WOO | reporter.nih.gov |
| Therapeutic selectivity of biased mu-opioid agonists. | NIH | National Institute on Drug Abuse | 2021 | $13,490 | April 2, 2019 | June 30, 2021 | ZAMARRIPA, CARLOS AUSTIN | reporter.nih.gov |
| Collaborative Care Office-Based Opioid Treatment for Adolescents and Young Adults | NIH | National Institute on Drug Abuse | 2021 | $564 | July 1, 2018 | July 14, 2021 | HADLAND, SCOTT EVAN | reporter.nih.gov |
Organizations
| Organization | Place | NIH awards | NIH amount | NSF awards | NSF amount |
|---|---|---|---|---|---|
| Rbhs-School of Dental Medicine | Newark, NJ | 1 | $3.1 million | 0 | $0 |
| Opiant Pharmaceuticals, Inc. | Santa Monica, CA | 1 | $1.8 million | 0 | $0 |
| Anabios Corporation | San Diego, CA | 1 | $1.7 million | 0 | $0 |
| 21medtech LLC | Durham, NC | 1 | $1.7 million | 0 | $0 |
| University of Southern California | Los Angeles, CA | 1 | $1.2 million | 0 | $0 |
| Cari Health, Inc. | San Diego, CA | 1 | $1.2 million | 0 | $0 |
| University of Michigan at Ann Arbor | Ann Arbor, MI | 2 | $1.1 million | 0 | $0 |
| Washington University | Saint Louis, MO | 2 | $1 million | 0 | $0 |
| University of California, San Francisco | San Francisco, CA | 2 | $871,493 | 0 | $0 |
| Brigham and Women's Hospital | Boston, MA | 2 | $834,695 | 0 | $0 |
| Oregon Health & Science University | Portland, OR | 2 | $739,523 | 0 | $0 |
| Geisinger Clinic | Danville, PA | 1 | $737,349 | 0 | $0 |
| Mclean Hospital | Belmont, MA | 2 | $692,954 | 0 | $0 |
| University of Kentucky | Lexington, KY | 1 | $609,253 | 0 | $0 |
| University of California-Irvine | Irvine, CA | 1 | $588,750 | 0 | $0 |
| Brandeis University | Waltham, MA | 1 | $587,534 | 0 | $0 |
| Virginia Commonwealth University | Richmond, VA | 1 | $567,877 | 0 | $0 |
| Columbia University Health Sciences | New York, NY | 1 | $539,654 | 0 | $0 |
| University of California Los Angeles | Los Angeles, CA | 1 | $531,057 | 0 | $0 |
| Duke University | Durham, NC | 1 | $505,171 | 0 | $0 |
| Johns Hopkins University | Baltimore, MD | 2 | $505,063 | 0 | $0 |
| University of Texas HLTH Science Center | San Antonio, TX | 1 | $461,788 | 0 | $0 |
| Elysium Therapeutics, Inc. | Lyons, CO | 1 | $452,530 | 0 | $0 |
| Icahn School of Medicine at Mount Sinai | New York, NY | 2 | $418,532 | 0 | $0 |
| University of Wisconsin-Madison | Madison, WI | 1 | $394,779 | 0 | $0 |
| Ochsner Clinic Foundation | New Orleans, LA | 1 | $378,392 | 0 | $0 |
| National Health Promotion Associates | White Plains, NY | 1 | $371,950 | 0 | $0 |
| SUNY Downstate Medical Center | Brooklyn, NY | 1 | $351,379 | 0 | $0 |
| Univ of North Carolina Chapel Hill | Chapel Hill, NC | 1 | $349,875 | 0 | $0 |
| Emory University | Atlanta, GA | 1 | $332,121 | 0 | $0 |
| Scripps Florida | Jupiter, FL | 2 | $308,392 | 0 | $0 |
| University of California at Davis | Davis, CA | 1 | $280,577 | 0 | $0 |
| University of Washington | Seattle, WA | 1 | $241,782 | 0 | $0 |
| Elevateu | Los Angeles, CA | 1 | $238,994 | 0 | $0 |
| Boston Medical Center | Boston, MA | 3 | $196,145 | 0 | $0 |
| University of Utah | Salt Lake City, UT | 1 | $190,625 | 0 | $0 |
| Univ of Massachusetts Med SCH Worcester | Worcester, MA | 1 | $188,616 | 0 | $0 |
| Brown University | Providence, RI | 1 | $186,362 | 0 | $0 |
| University of Pittsburgh at Pittsburgh | Pittsburgh, PA | 1 | $180,021 | 0 | $0 |
| University of Pennsylvania | Philadelphia, PA | 1 | $177,902 | 0 | $0 |
| University of Maryland Baltimore | Baltimore, MD | 1 | $175,792 | 0 | $0 |
| Ndri-Usa, Inc. | New York, NY | 1 | $167,983 | 0 | $0 |
| Texas State University - San Marcos | San Marcos, TX | 1 | $135,875 | 0 | $0 |
| DMK Pharmaceuticals, Inc. | Somerville, NJ | 1 | $55,000 | 0 | $0 |
| Opiaid, Inc. | Wilmington, NC | 1 | $55,000 | 0 | $0 |
| West Virginia University Research Corporation | Morgantown, WV | 1 | $53,965 | 0 | $0 |
| Marquette University | Milwaukee, WI | 1 | $31,156 | 0 | $0 |
| University of Minnesota | Minneapolis, MN | 1 | $26,961 | 0 | $0 |
| University of Mississippi Med CTR | Jackson, MS | 1 | $13,490 | 0 | $0 |
Funding by fiscal year
| Fiscal year | NIH awards | NIH amount | NSF awards | NSF amount |
|---|---|---|---|---|
| 2021 | 60 | $27,675,938 | 0 | $0 |
Open federal funding opportunities
From Grants.gov: notices that funded awards in this table, and open notices on the same agency and assistance listing.
Updated November 3, 2026. Read from NIH RePORTER ExPORTER and NSF Award Search. Published by NIH and NSF as U.S. government data. NIH awards are fiscal years 2021 to 2025 (NIH files published to 2026-07-09); NSF awards are fiscal years 2022 to 2026 (NSF files published to 2026-11-02). NIH amounts are the total cost of each fiscal year in the window; NSF amounts are the funds obligated in the window. Organizations are matched on the UEI. Open opportunities come from Grants.gov and match on agency and assistance listing number, and on the notice number NIH prints on an award. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.